Surgery and Therapy for Cervical Cancer

Abstract

The human papillomavirus (HPV) is the primary cause of cervical cancer, which is the fourth most frequent malignancy in women globally. Cervical intraepithelial lesions caused by high-risk HPV strains have the potential to develop into cervical cancer over time. The majority of screening and early detection initiatives in the US and other affluent nations use Papanicolaou (Pap) smears and HPV testing. While Pap screenings detect aberrant cytology, HPV testing detects exposure to both low- and high-risk forms of HPV.

The majority of cases of cervical cancer may be avoided. The best strategies for lowering the healthcare burden and death associated with cervical cancer are primary prevention and screening. Cervical cancer has been prevented by HPV vaccination since 2006. Inter professional team members need young female patients and their families about the great effectiveness of this vaccination (preferably, before they start having sex). Primary preventive measures, screening recommendations, diagnostic assessments, current staging, and particular treatment options for invasive cervical cancer are all covered in this activity.